Mumbai, April 19 -- Molecules has expanded its global footprint by establishing a facility in Tokyo to accelerate collaborative research programmes involving academia, industry and technology partners across Japan, India and other key innovation hubs, the company said.
The move marks a strategic milestone in its efforts to build an interconnected global research and innovation ecosystem. Led by Dr. Sreeraj Gopi, the company is developing structurally validated delivery platforms, including liposomal and vesicular systems such as Metazome, to enhance bio-availability, stability and functional outcomes.
Japan's advanced research infrastructure and precision-driven ecosystem make it an ideal destination to scale next-generation delivery tech...